mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.12 |
0.03 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.04 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.04 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.04 |